Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, continues to be a global health concern. Early detection and prompt treatment are essential in controlling the spread of the disease. This article provides an overview of the current advancements and innovations in TB detection.
The GeneXpert MTB/RIF assay, endorsed by the World Health Organization, is a rapid molecular test that detects TB and rifampicin resistance. It offers a significant improvement over conventional smear microscopy, with higher sensitivity and specificity, and results available within two hours.
LAMP is a simple, rapid, and cost-effective molecular diagnostic tool. It amplifies the DNA of Mycobacterium tuberculosis at a constant temperature, providing results within an hour. LAMP’s high sensitivity and specificity make it a promising tool for TB detection, especially in resource-limited settings.
IGRAs are blood tests that measure the immune response to TB proteins. They are more specific than the traditional tuberculin skin test and can distinguish between latent TB infection and active disease. However, they cannot determine if the disease is drug-resistant.
Advancements in imaging techniques, such as high-resolution computed tomography (HRCT) and positron emission tomography-computed tomography (PET-CT), have improved the detection of pulmonary and extra-pulmonary TB. These techniques provide detailed images of the disease’s extent and can guide biopsy procedures.
The advancements and innovations in TB detection are promising, offering more rapid and accurate diagnosis. However, challenges remain, such as the need for point-of-care tests, the detection of drug-resistant strains, and the differentiation between latent and active TB. Continued research and development in this field are essential for the global control of TB.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation